Time & location: 10:00 AM ET, Virtual
ACCESS RECORDING
In this on-demand webinar, join experts from Quanterix as they outline strategies for streamlining performance study submissions, aligning with regulatory requirements, and accelerating timelines for submission and approval across individual countries. Learn how Quanterix’s proven experience and collaborative approach can simplify the process while ensuring high-quality results. Whether just starting an IVDR process or optimizing ongoing studies, this session will provide actionable insights to drive readiness and success.
What you will learn:
-
- Gain a clear understanding of when a performance study is required and how IVDR regulations impact biomarker use.
- Learn the key elements of a compliant submission, from assay validation to regulatory documentation.
- Discover best practices for synchronizing sample collection, data analysis, and regulatory timelines.
- Get insights into efficient workflows, risk mitigation strategies, and tools to accelerate regulatory approvals.
- Learn how our experience, precision, and tailored approach can help you avoid delays and ensure compliance.
- Understand realistic timeframes and how to start your EU IVDR performance study with confidence.
Speakers:
-
-
- Brian Ciccariello, VP, Quality and Regulatory Affairs
- Christina Raso, Program Manager
-
ACCESS RECORDING
Related Posts
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…
Tertiary Lymphoid Structures in Cancer Immunotherapy: Insights and Perspectives
Tertiary lymphoid structures (TLS) have emerged as critical components of the tumor microenvironment, influencing immune responses and clinical outcomes in cancer.
